Post-Traumatic Stress Disorder Clinical Trial
Official title:
Pilot Evaluation of the VetChange Mobile App for Veterans With PTSD Who Engage in Problem Drinking
Verified date | July 2017 |
Source | VA Palo Alto Health Care System |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Concept: Alcohol misuse is common among Veterans with PTSD. It has been proposed that this
high comorbidity is the result of "self-medication," with alcohol being used to alleviate
common PTSD symptoms (e.g., hyperarousal, sleep problems). Given this high prevalence and
functional relationship, researchers at the BSD of the NCPTSD developed the VetChange
self-management website to concurrently address these conditions. In a large scale RCT,
VetChange has shown efficacy to reduce both alcohol misuse and PTSD symptoms. Unfortunately,
the recently launched publicly available VetChange website (Vetchange.org) has been plagued
by a high rate of visitors not completing the mandatory registration process, which is
required for repeated use. Based on the promising findings of the VetChange research, the D&T
Division partnered with the BSD Division to develop the VetChange mobile app, which is set to
be released to the public very soon. However, unlike the VetChange website, the app has not
yet been evaluated and has the advantage of allowing users to easily obtain it without having
to register and repeatedly log on through an Internet connection.
This research partnership between the D&T and BSD Divisions will extend and enhance an
ongoing successful cross-center collaboration in a high priority topic for the larger Center.
The purpose of this proposal is to conduct a pilot evaluation of the VetChange mobile app in
order to test its feasibility, acceptability, and potential efficacy to reduce alcohol
consumption, PTSD severity, and improve psychosocial functioning among Veterans with PTSD who
exhibit signs of problem drinking. In this study, 280 Veterans with problem drinking and
clinically significant PTSD symptoms will be recruited using social media and randomized in
equal numbers to receive one of four conditions: 1) Assessment only, 2) VetChange mobile app
only, 3) AFT plus the VetChange mobile app supplemented with a package of supportive
accountability tools (VetChange+). In addition to receiving the mobile app, VetChange+
participants will receive SMS reminders to log drinking behavior using the mobile app. The
investigators will track objective use of the VetChange mobile app to assess feasibility, and
this usage data will also be used in real-time to tailor the content of text messages
provided to participants in the VetChange+ condition. Participants will complete measures of
alcohol use, functional well-being, and PTSD symptoms at baseline and again after 8 weeks
(posttreatment). At post-treatment, participants in the VetChange app arms of the study will
also be asked to report their level of satisfaction with the app and to complete a brief
qualitative evaluation of their experience using the VetChange mobile app.
Results of this pilot study will be used to characterize the feasibility, acceptability, and
potential efficacy of a mobile app-based self-management intervention to reduce problem
drinking behavior in Veterans with PTSD, will inform optimization of the intervention, and
will serve as the foundation for subsequent proposals for extramural funding.
Status | Not yet recruiting |
Enrollment | 280 |
Est. completion date | December 2018 |
Est. primary completion date | June 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: 1. self-reported status as OEF or OIF veteran, 2. age between 18 and 65 years, 3. moderate levels of nondependent problem drinking as determined by score on the Alcohol Use Disorders Identification Test (AUDIT; Babor, de la Fuente, Saunders, & Grant, 1992; Bradley et al., 2003) between 8 and 25 for men and 5 and 25 for women, 4. drinking above guidelines for safer drinking during the 30 days prior to screening based on the Quick Drink Screen (L. C. Sobell et al., 2003; no more than 4 drinks per occasion or 14 drinks per week for men and no more than three drinks per occasion or seven drinks per week for women; Dawson, Grant, & Li, 2005; U.S. Department of Health and Human Services & U.S. Department of Agriculture, 2010), and 5. willing to provide an e-mail address for reminders and incentives. Exclusion Criteria: (a) high alcohol problem severity |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Eric Kuhn |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Quick Drink Screen (QDS; Sobell et al., 2003) | 4-item self-report measure of alcohol consumption focused on quantity and frequency of drinking in the last 30 days | 8 weeks | |
Primary | PTSD Checklist-5 (PCL-5; Weathers et al., 2010) | 20-item self-report measure of PTSD symptoms | 8 weeks | |
Secondary | The Short Inventory of Problems (SIP; Miller, Tonigan, & Longabaugh, 1995) | 15-item, self-report of alcohol-related problems | 8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04317820 -
Deep Brain Reorienting in Post-traumatic Stress Disorder
|
N/A | |
Completed |
NCT05112003 -
Translingual Neurostimulation for the Virtual Treatment of Post-Traumatic Stress Disorder: A Feasibility Pilot
|
N/A | |
Recruiting |
NCT04518267 -
Anger and Psychotrauma: Data From Military and Civilians
|
||
Completed |
NCT02502604 -
Cognitive Training Program for Individuals With Depression and Post-Traumatic Stress Disorder
|
N/A | |
Completed |
NCT02256566 -
Cognitive Training for Mood and Anxiety Disorders
|
N/A | |
Terminated |
NCT02234687 -
A mGlu2/3 Agonist in the Treatment of PTSD
|
Phase 1 | |
Terminated |
NCT02520726 -
PTSD Prevention Study Examining the Efficacy of Sertraline in Burn Victims
|
Phase 4 | |
Completed |
NCT01738308 -
The Effects of Healing Touch on Post Operative Pediatric Patients
|
N/A | |
Completed |
NCT02213900 -
Preventing Post-Operative Delirium in Patients Undergoing a Pneumonectomy, Esophagectomy or Thoracotomy
|
Phase 4 | |
Completed |
NCT01437891 -
Sentra AM® and Sentra PM® for Post-traumatic Stress Disorder (PTSD) and Gulf War Fibromyalgia (GWF)
|
N/A | |
Completed |
NCT01517711 -
Tramadol Extended-Release (ER) for Posttraumatic Stress Disorder (PTSD)
|
Phase 4 | |
Completed |
NCT01998100 -
Maximizing Treatment Outcome in Post-Traumatic Stress Disorder (PTSD)
|
Phase 3 | |
Completed |
NCT01199107 -
Maximizing Treatment Outcome and Examining Sleep in Post-traumatic Stress Disorder (PTSD)
|
Phase 3 | |
Completed |
NCT01231711 -
Improving Quality-of-life and Depressive Symptoms of Combat Veterans Via Internet-based Intervention
|
Phase 1 | |
Completed |
NCT00838006 -
Psychophysiologic Predictors of Post-deployment Mental Health Outcomes
|
N/A | |
Completed |
NCT00680524 -
Telephone-based Care for OEF/OIF Veterans With PTSD
|
N/A | |
Completed |
NCT00348036 -
Group Intervention for Interpersonal Trauma
|
N/A | |
Completed |
NCT00525226 -
Evaluating the Effects of Stress in Pregnancy
|
N/A | |
Completed |
NCT00127673 -
Comparison of Two Treatments for Post-Traumatic Stress Disorder
|
Phase 3 | |
Completed |
NCT00158262 -
Effect of Propranolol on Preventing Posttraumatic Stress Disorder
|
Phase 4 |